WHO's decision to resume HCQ clinical trial a step in right direction, say experts

The global heath body had earlier suspended the hydroxychloroquine (HCQ) arm of the clinical trials of experimental COVID-19 drugs over safety concerns. However on Wednesday, it recommended the trial to be continued following a review of safety data.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2XwEbx2
via IFTTT